Literature DB >> 10806996

Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments.

C A Stein1.   

Abstract

Antisense oligonucleotides are invaluable reagents for the specific downregulation of gene expression. In the absence of a carrier, charged oligonucleotides (e.g., phosphorothioates) can interact with a large number of cell surface proteins, but tend to be internalized into the endosomal/lysosomal compartment. However, they can be successfully delivered to the nuclei of diverse cell types via the use of a wide variety of reagents, including cationic lipids, and cationic polyamines. Over the past several years, a more general understanding of the rules governing the interpretation of data derived from antisense experiments has been reached. These are discussed with emphasis on how to avoid some of the confounding features of this important, emerging technology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10806996     DOI: 10.1016/s0167-4781(99)00143-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain.

Authors:  Mahesh M Thakkar; Stuart Winston; Robert W McCarley
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

3.  Effect of target secondary structure on RNAi efficiency.

Authors:  Yu Shao; Chi Yu Chan; Anil Maliyekkel; Charles E Lawrence; Igor B Roninson; Ye Ding
Journal:  RNA       Date:  2007-08-07       Impact factor: 4.942

4.  Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.

Authors:  S Patrick Walton; Gregory N Stephanopoulos; Martin L Yarmush; Charles M Roth
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

5.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

Review 6.  Genetically engineered intracellular single-chain antibodies in gene therapy.

Authors:  Guadalupe Bilbao; Juan Luis Contreras; David T Curiel
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

7.  Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond.

Authors:  Y Ding; C E Lawrence
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

8.  A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma.

Authors:  Xiaoming Yao; Ji-Fan Hu; Mark Daniels; Hadas Shiran; Xiangjun Zhou; Huifan Yan; Hongqi Lu; Zhilan Zeng; Qingxue Wang; Tao Li; Andrew R Hoffman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

9.  Novel antisense oligonucleotides containing hydroxamate linkages: targeted iron-triggered chemical nucleases.

Authors:  Marvin J Miller; Hui Li; Catherine A Foss
Journal:  Biometals       Date:  2009-01-28       Impact factor: 2.949

10.  Modified single-stranded oligonucleotides inhibit aggregate formation and toxicity induced by expanded polyglutamine.

Authors:  Hetal Parekh-Olmedo; Jin Wang; James F Gusella; Eric B Kmiec
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.